The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model

Constitutive androstane receptor (CAR) and pregnane X receptor (PXR) are closely related nuclear receptors with overlapping regulatory functions in xenobiotic clearance but distinct roles in endobiotic metabolism. Car activation has been demonstrated to ameliorate hypercholesterolemia by regulating cholesterol metabolism and bile acid elimination, whereas PXR activation is associated with hypercholesterolemia and liver steatosis. Here we show a human CAR agonist/PXR antagonist, MI-883, which effectively regulates genes related to xenobiotic metabolism and cholesterol/bile acid homeostasis by leveraging CAR and PXR interactions in gene regulation. Through comprehensive analyses utilizing lipidomics, bile acid metabolomics, and transcriptomics in humanized PXR-CAR-CYP3A4/3A7 mice fed high-fat and high-cholesterol diets, we demonstrate that MI-883 significantly reduces plasma cholesterol levels and enhances fecal bile acid excretion. This work paves the way for the development of ligands targeting multiple xenobiotic nuclear receptors. Such ligands hold the potential for precise modulation of liver metabolism, offering new therapeutic strategies for metabolic disorders.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-02-06
DOI
https://doi.org/10.1038/s41467-025-56642-y
Citations
9
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
14.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model

Magnus Ingelman‐Sundberg, Klára Dohnalová, Karel Chalupský, Michaela Chocholoušková et al.
9 citations
Nature Communications
Pharmacogenetics and Drug Metabolism
14.02
article

The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model

Magnus Ingelman‐Sundberg, Klára Dohnalová, Karel Chalupský, Michaela Chocholoušková, Radim Nencka, Oliver Burk, Rajamanikkam Kamaraj, Josef Škoda, Petr Pávek, M Hroch, Stanislav Mičuda, Lucie Smutná, Michal Holčapek, Ivana Mejdrová, Tomáš Smutný, Jana Hricová, Rinie van Beuningen, Azam Rashidian, Ivona Pávková, Dirk Pijnenburg, Thales Kronenberger, Martin Leníček, Libor Vı́tek, Kryštof Škach, Ján Dušek, Mária Krutáková
article en
9 citations

Abstract

Constitutive androstane receptor (CAR) and pregnane X receptor (PXR) are closely related nuclear receptors with overlapping regulatory functions in xenobiotic clearance but distinct roles in endobiotic metabolism. Car activation has been demonstrated to ameliorate hypercholesterolemia by regulating cholesterol metabolism and bile acid elimination, whereas PXR activation is associated with hypercholesterolemia and liver steatosis. Here we show a human CAR agonist/PXR antagonist, MI-883, which effectively regulates genes related to xenobiotic metabolism and cholesterol/bile acid homeostasis by leveraging CAR and PXR interactions in gene regulation. Through comprehensive analyses utilizing lipidomics, bile acid metabolomics, and transcriptomics in humanized PXR-CAR-CYP3A4/3A7 mice fed high-fat and high-cholesterol diets, we demonstrate that MI-883 significantly reduces plasma cholesterol levels and enhances fecal bile acid excretion. This work paves the way for the development of ligands targeting multiple xenobiotic nuclear receptors. Such ligands hold the potential for precise modulation of liver metabolism, offering new therapeutic strategies for metabolic disorders.

Nature CommunicationsVol. 16(1)
University of Pardubice (CZ), University of Eastern Finland (FI), Charles University (CZ), Karolinska Institutet (SE), Institute of Organic Chemistry (PL), Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (DE), PamGene (Netherlands) (NL), University Hospital Hradec Králové (CZ), Czech Academy of Sciences, Institute of Molecular Genetics (CZ), Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry (CZ), General University Hospital in Prague (CZ), Institute of Pharmacology (CZ), University of Hradec Králové (CZ), University of Tübingen (DE), University of Defence (CZ)
Univerzita Karlova v Praze, Itä-Suomen Yliopisto, European Commission, Ministerstvo Školství, Mládeže a Tělovýchovy, Grantová Agentura České Republiky, Bundesministerium für Bildung und Forschung, Karolinska Institutet, Akademie Věd České Republiky, China Scholarship Council, Ministerstvo Obrany České Republiky, Univerzita Pardubice, Všeobecná Fakultní Nemocnice v Praze, Ústav Molekulární Genetiky, Akademie Věd České Republiky, lékařská fakulta Univerzity Karlovy, Ústav organické chemie a biochemie Akademie věd České republiky
Good health and well-being
Openalex Percentile: Top 1%
Pharmacogenetics and Drug Metabolism
14.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.